Uniper has joined a growing list of aviation fuel buyers that have reserved future production capacity from Syzygy Plasmonics' NovaSAF™ platform, as commercial momentum behind the company's SAF technology continues to build.
The agreement adds to Uniper's low carbon portfolio and brings additional commercial traction to Syzygy's planned NovaSAF™ facilities in Central and South America, as NovaSAF-1 in Uruguay approaches a final investment decision.
More importantly, the agreement for Syzygy's dual-certified pathway helps to enhance the European Union's ability to meet mandate targets for both bio and RFNBO SAF.
Trevor Best, CEO Syzygy Plasmonics, said: "Uniper's decision to reserve NovaSAF™ capacity reflects the commercial traction our platform is attracting at the moment when it is most needed to meet mandate volumes. Agreements like this affirm that the market is moving to meet EU commission targets and companies like Syzygy have the right product, at the right time, with the right volumes."
Benedikt Messner, SVP New Energies, Uniper, said: "Uniper is committed to building a diversified portfolio of low-carbon energy solutions that support our customers' decarbonization goals. Securing access to Syzygy's innovative technology is another important step in building our position in a market with significant growth potential and complements our recent announcements in advancing our sustainable fuels strategy."
